参考文献/References:
[1] LLOVET J M,KELLEY R K,VILLANUEVA A,et al.Hepatocellular carcinoma[J].Nat Rev Dis Primers,2021,7(1):6.
[2] 陈萍,马小平,蔡爽,等.过表达叉头盒F1对肝癌细胞增殖、周期和凋亡的影响及机制实验研究[J].陕西医学杂志,2023,52(9):1145-1149.
[3] RUMGAY H,ARNOLD M,FERLAY J,et al.Global burden of primary liver cancer in 2020 and predictions to 2040[J].J Hepatol,2022,77(6):1598-1606.
[4] LEI Y,XU X,LIU H,et al.HBx induces hepatocellular carcinogenesis through ARRB1-mediated autophagy to drive the G1/S cycle[J].Autophagy,2021,17(12):4423-4441.
[5] 杨梅,迪丽美合日?迪力夏提,赵翡翠.基于网络药理学的准噶尔乌头炮制品抗卵巢癌作用机制研究[J].实用临床医药杂志,2021,25(24):1-9.
[6] TUFAIL M.HOTAIR in colorectal cancer:Structure,function,and therapeutic potential[J].Med Oncol,2023,40(9):259.
[7] CHEN L,QIAN X,WANG Z,et al.The HOTAIR lncRNA:A remarkable oncogenic promoter in human cancer metastasis[J].Oncol Lett,2021,21(4):302.
[8] CAO W,SUN Y,LIU L,et al.HOTAIR mediates cisplatin resistance in nasopharyngeal carcinoma by regulating miR-106a-5p/SOX4 axis[J].Bioengineered,2022,13(3):6567-6578.
[9] HUANG D Q,MATHURIN P,CORTEZ-PINTO H,et al.Global epidemiology of alcohol-associated cirrhosis and HCC:Trends,projections and risk factors[J].Nat Rev Gastroenterol Hepatol,2023,20(1):37-49.
[10] BARRERA-CORTES R I,RODRIGUEZ-TORRES E E,VAZQUEZ-MENDOZA E,et al.Liver cancer in Hidalgo State,Mexico:Analysis of the status,risk factors and regional public health policy requirements:A cross-sectional correlational study[J].Sao Paulo Med J,2022,140(4):574-582.
[11] LI X,RAMADORI P,PFISTER D,et al.The immunological and metabolic landscape in primary and metastatic liver cancer[J].Nat Rev Cancer,2021,21(9):541-557.
[12] HU M,ZHANG R,YANG J,et al.The role of N-glycosylation modification in the pathogenesis of liver cancer[J].Cell Death Dis,2023,14(3):222.
[13] HEINRICH S,CRAIG A J,MA L,et al.Understanding tumour cell heterogeneity and its implication for immunotherapy in liver cancer using single-cell analysis[J].J Hepatol,2021,74(3):700-715.
[14] LI Q,NI Y,ZHANG L,et al.HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation[J].Signal Transduct Target Ther,2021,6(1):76.
[15] YIN S,JIN W,QIU Y,et al.Solamargine induces hepatocellular carcinoma cell apoptosis and autophagy via inhibiting LIF/miR-192-5p/CYR61/Akt signaling pathways and eliciting immunostimulatory tumor microenvironment[J].J Hematol Oncol,2022,15(1):32.
[16] WONG M M,CHAN H Y,AZIZ N A,et al.Interplay of autophagy and cancer stem cells in hepatocellular carcinoma[J].Mol Biol Rep,2021,48(4):3695-3717.
[17] KAWANO Y,KANEYA Y,AOKI Y,et al.Medical treatment for hepatocellular carcinoma in Japan[J].J Nippon Med Sch,2022,89(2):154-160.
[18] 王芳,胡洁琼,冯彦虎,等.次乌头碱通过cGAS/STING通路调节胃癌细胞增殖、迁移、侵袭和免疫逃逸[J].中国免疫学杂志,2023,39(10):2178-2183.
[19] 左慧琳,李小翠,区晓君,等.多药耐药蛋白1a对苯甲酰新乌头原碱的效-毒-体内暴露的调控研究[J].中药新药与临床药理,2023,34(7):959-969.
[20] 马远,孙克伟.苯甲酰乌头原碱对HBV-ACLF阳黄证和阴黄证患者外周血树突细胞功能的影响[J].中医药信息,2023,40(5):39-44.
[21] TAN Y T,LIN J F,LI T,et al.LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer[J].Cancer Commun(Lond),2021,41(2):109-120.
[22] 洪甲,杨洋,栾丽霞.lncRNA-p23154通过miR-375/KLF4途径对SKOV3细胞增殖、侵袭的影响[J].陕西医学杂志,2021,50(11):1336-1339.
[23] 宇汝翠,陆智慧,李金虎,等.益气养阴通络方通过lncRNA UCA1靶向调控miR-485-5p抑制糖尿病肾病大鼠肾小管上皮细胞凋亡及炎症反应作用机制[J].陕西中医,2023,44(8):1000-1004.
[24] 卓少华,丘远聪,郑俊德,等.人参皂苷Rg5调控lncRNA-PCAT12抑制胃癌细胞生长实验研究[J].陕西中医,2020,41(4):437-439.
[25] ZHANG J,CHEN K,TANG Y,et al.LncRNA-HOTAIR activates autophagy and promotes the imatinib resistance of gastrointestinal stromal tumor cells through a mechanism involving the miR-130a/ATG2B pathway[J].Cell Death Dis,2021,12(4):367.
[26] HAN C,YANG Y,GUO L,et al.The expression of long non-coding RNA HOTAIR in advanced hepatocellular carcinoma and its prognostic correlation with sunitinib therapy[J].Arch Med Sci,2021,18(1):71-78.
[27] LOU Z H,XU K Y,QIAO L,et al.Diagnostic potential of the serum lncRNAs HOTAIR,BRM and ICR for hepatocellular carcinoma[J].Front Biosci(Landmark Ed),2022,27(9):264.
[28] GUO Y,LIU B,HUANG T,et al.HOTAIR modulates hepatocellular carcinoma progression by activating FUT8/core-fucosylated Hsp90/MUC1/STAT3 feedback loop via JAK1/STAT3 cascade[J].Dig Liver Dis,2023,55(1):113-122.
[29] LI T,LIU N,GAO Y,et al.Long noncoding RNA HOTAIR regulates the invasion and metastasis of prostate cancer by targeting hepaCAM[J].Br J Cancer,2021,124(1):247-258.
[30] 杨良.lncRNA HOTAIR调控肝癌细胞自噬的机制研究[D].沈阳:中国医科大学,2016.
相似文献/References:
[1]张慧贤,马向明,付庆江,等.肝细胞癌患者血清IL-17细胞因子水平检测的临床意义[J].陕西医学杂志,2016,(10):1394.
[2]苏艳丽,冯 军.血栓弹力图和常规凝血四项检测在评估肝癌患者围术期凝血功能中的应用研究*[J].陕西医学杂志,2019,(7):846.
SU Yanli,FENG Jun..Application of thromboelastography and conventional coagulation in evaluating perioperative coagulation function in patients with liver cancer[J].,2019,(6):846.
[3]李玉龙,宗 伟,常素娥,等.微小RNA-195通过靶向BIRC5调控肝癌Hep3B细胞凋亡实验研究[J].陕西医学杂志,2022,51(3):270.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.002]
LI Yulong,ZONG Wei,CHANG Su'e,et al.Experimental study of miRNA-195 regulating apoptosis of hepatoma Hep3B cells by targeting BIRC5[J].,2022,51(6):270.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.002]
[4]吴许军,李文阳,张甲戌.靶向肝癌抗肿瘤疫苗临床研究进展[J].陕西医学杂志,2022,51(12):1611.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.034]
WU Xujun,LI Wenyang,ZHANG Jiaxu.Clinical research progress of targeted anti-tumor vaccines for hepatocellular carcinoma[J].,2022,51(6):1611.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.034]
[5]曹振振,韩会会,杨文义.肝癌患者血清成纤维细胞生长因子21和富亮氨酸α2糖蛋白1表达情况及临床意义[J].陕西医学杂志,2023,52(3):305.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.013]
CAO Zhenzhen,HAN Huihui,YANG Wenyi.Expression of FGF21 and LRG1 in serum of patients with hepatocellular carcinoma and its clinical diagnostic value[J].,2023,52(6):305.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.013]
[6]董 勇,程 序,梁 晗,等.肝癌组织角蛋白23表达与患者临床病理特征及预后关系研究[J].陕西医学杂志,2023,52(6):756.[doi:DOI:10.3969/j.issn.1000-7377.2023.06.026]
DONG Yong,CHENG Xu,LIANG Han,et al.Relationship between keratin 23 expression and clinicopathological features and prognosis of patients with hepatocellular carcinoma[J].,2023,52(6):756.[doi:DOI:10.3969/j.issn.1000-7377.2023.06.026]
[7]吴 洁,田鑫越,秦耐宇,等.艾司氯胺酮对肝癌细胞恶性生物学行为的影响及作用机制实验研究[J].陕西医学杂志,2024,(8):1041.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.007]
WU Jie,TIAN Xinyue,QIN Naiyu,et al.Effect of esketamine on malignant biological behavior of hepatocellular carcinoma cells and its mechanism[J].,2024,(6):1041.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.007]